Tag: bioequivalence

Clinician Communication: Impact on Patient Beliefs About Generics

Explore how clinician communication shapes patient beliefs about generic drugs. Learn how to overcome skepticism, manage the nocebo effect, and improve adherence with proven strategies.

Details

Pharmacokinetic Studies: The Real Standard for Proving Generic Drug Equivalence

Pharmacokinetic studies are the primary method used to prove generic drugs work like brand-name versions. But they're not perfect. Learn how Cmax and AUC measurements work, why regulators are moving beyond them, and what this means for your medication safety.

Details

Bioequivalence of Combination Products: Special Testing Challenges Explained

Combination products like multi-drug pills, inhalers, and topical creams face unique bioequivalence challenges that delay generic access. Learn why testing them is harder, costlier, and more complex than single-drug generics.

Details

Bioavailability Studies for Generics: What They Test and Why

Bioavailability studies ensure generic drugs work like brand-name versions by measuring how much and how fast the active ingredient enters the bloodstream. The FDA uses AUC and Cmax data to confirm equivalence within an 80-125% range.

Details

Generic vs Brand Rosuvastatin (Crestor): Key Differences Explained

Learn the real differences between generic rosuvastatin and brand-name Crestor, covering efficacy, safety, price, and when each option is best for you.

Details